Claritev Corporation(CTEV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CTEV Claritev Corporation

Post-Mkt 09-09 17:17:53 EDT

36.29

-1.42

-3.77%

盘后36.29

+0.000.00%

16:10 EDT

High37.71	Low35.66	Vol119.20K
Open37.71	D1 Closing37.71	Amplitude5.45%
Mkt Cap615.73M	Tradable Cap204.59M	Total Shares16.97M
T/O4.34M	T/O Rate2.11%	Tradable Shares5.64M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CTEV","market":"US","secType":"STK","nameCN":"Claritev Corporation","latestPrice":36.29,"timestamp":1788984000000,"preClose":37.71,"halted":0,"volume":119202,"hourTrading":{"tag":"盘后","latestPrice":36.29,"preClose":36.29,"latestTime":"16:10 EDT","volume":726,"amount":26346.54,"timestamp":1788984605221,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.037655794219040084,"floatShares":5637600,"shares":16966900,"eps":-16.987898,"marketStatus":"Post-Mkt","change":-1.42,"latestTime":"09-09 17:17:53 EDT","open":37.71,"high":37.71,"low":35.655,"amount":4338357,"amplitude":0.054495,"askPrice":36.76,"askSize":1,"bidPrice":28.35,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-16.987898,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788998400000},"marketStatusCode":4,"adr":0,"exchange":"NYSE","adjPreClose":37.71,"preHourTrading":{"tag":"盘前","latestPrice":38.01,"preClose":37.71,"latestTime":"09:29 EDT","volume":300,"amount":11344.491,"timestamp":1788960546306,"change":0.3,"changeRate":0.007955,"amplitude":0.047468},"postHourTrading":{"tag":"盘后","latestPrice":36.29,"preClose":36.29,"latestTime":"16:10 EDT","volume":726,"amount":26346.54,"timestamp":1788984605221,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.18768,"impliedVol":1.0064,"impliedVolPercentile":0.3506},"requestUrl":"/m/hq/s/CTEV/wiki","defaultTab":"wiki","newsList":[{"id":"2666953828","title":"Claritev Says Healthcare Pricing Intelligence Turns Transparency Data into Operational Cost-Management Tool","url":"https://stock-news.laohu8.com/highlight/detail?id=2666953828","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666953828?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:15","pubTimestamp":1788956117,"startTime":"0","endTime":"0","summary":"Claritev says healthcare pricing intelligence turns transparency data into operational cost-management toolClaritev published a strategic market analysis on Sep. 9, 2026, outlining how pricing intelli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL24Hsp1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663030170","title":"Claritev CEO and Executive Chair Dalton Travis Reports $249,909 Purchase of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2663030170","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663030170?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:50","pubTimestamp":1788180655,"startTime":"0","endTime":"0","summary":"Claritev CEO and Executive Chair Dalton Travis reports $249,909 purchase of common sharesClaritev President, CEO, Executive Chair, director Dalton Travis reported open-market purchases of Class A comm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL2G3GP4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Claritev CEO and Executive Chair Dalton Travis Reports $249,909 Purchase of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662581702","title":"Claritev Management to Present at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662581702","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662581702?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:01","pubTimestamp":1787832103,"startTime":"0","endTime":"0","summary":"Claritev management to present at Morgan Stanley global healthcare conferenceClaritev management will meet investors at the Wells Fargo 21st Annual Healthcare Conference on Sept. 9, 2026, in Boston.Sm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL3GXMCR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0256863902.USD","LU0210528500.USD","TFNS","LU2430703095.HKD","VFH","FTXO","LU2746668974.SGD","LU0106261372.USD","JPMO","IYG","LU0225283273.USD","LU1894683348.USD","LU1116320737.USD","LU1974910355.USD","LU0820561818.USD","LU1074936037.SGD","LU2237443382.USD","IAI","LU0234570918.USD","XLF","IE000M9KFDE8.USD","LU0187121727.USD","IE00BZ1G4Q59.USD","TRUF","LU2054465674.USD","LU2456880835.USD","IXG","KBWB","JPO","LU2552382058.USD","LU1119994496.HKD","CTEV","LU1280957306.USD","LU0158827781.USD","LU0149725797.USD","UYG","LU0256863811.USD","LU1668664300.SGD","IE00BLSP4452.SGD","LU0868494708.USD","LU2023250330.USD","IE00B1BXHZ80.USD","LU2237443622.USD","LU1732800096.USD","LU2242649171.HKD","LU0323591593.USD","LU0795875086.SGD","FNCL","IE00BJLML261.HKD","IYF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250734","title":"U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250734","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250734?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:26","pubTimestamp":1787297213,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Health Catalyst, Nektar Therapeutics, TIC SolutionsAug 21 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, incl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL8N44I09H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FIX","MATW","HL","LEGR","AVGU","HRZN","APP","MTSI","IXN","LYTS","MBX","DISK","LMB","MU","MRVL","CHAT","BCAL","FTH","ABT","BAI","AAP","SMHX","VEGI","BWMN","PI","ADI","EBS","EGGY","ADSK","DV","AMYY","COTY","FTAI","ECG","ACEL","DE","AMD","HCAT","INNV","TRFK","P","AMP","GTLB","QBTS","FERG","MCHP","CTEV","AVGO","DOCS","IMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661902236","title":"Claritev price target raised to $40 from $28 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2661902236","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661902236?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:30","pubTimestamp":1787243412,"startTime":"0","endTime":"0","summary":"Barclays analyst Glen Santangelo raised the firm’s price target on Claritev (CTEV) to $40 from $28 and keeps an Overweight rating on the shares. Pu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/claritev-price-target-raised-to-40-from-28-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/claritev-price-target-raised-to-40-from-28-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660978054","title":"Claritev Chief Growth Officer Tiffani Misencik Sells 8,850 Shares Worth $354,592.95","url":"https://stock-news.laohu8.com/highlight/detail?id=2660978054","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660978054?lang=en_us&edition=fundamental","pubTime":"2026-08-19 05:08","pubTimestamp":1787087285,"startTime":"0","endTime":"0","summary":"Claritev Chief Growth Officer Tiffani Misencik sells 8,850 shares worth $354,592.95Tiffani Misencik, SVP and Chief Growth Officer, sold 8,850 shares of Class A common stock on Aug. 14, 2026.Sale price","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL6k9k4C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Claritev Chief Growth Officer Tiffani Misencik Sells 8,850 Shares Worth $354,592.95","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660462560","title":"Claritev Shifts Payment Integrity Strategy Toward Pre-Pay Overpayment Prevention to Boost ROI","url":"https://stock-news.laohu8.com/highlight/detail?id=2660462560","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660462560?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:06","pubTimestamp":1787054801,"startTime":"0","endTime":"0","summary":"Claritev shifts payment integrity strategy toward pre-pay overpayment prevention to boost ROIClaritev outlined a shift in payment integrity toward pre-payment prevention, aiming to reduce improper pay","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL8TbdhV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480741","title":"Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480741","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480741?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:02","pubTimestamp":1786971759,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nFWN44E0VD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","MRAI","CTEV","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480718","title":"Claritev Expands Marpai Partnership to Add Pre- and Post-Payment Claims Integrity Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480718","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480718?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:01","pubTimestamp":1786971667,"startTime":"0","endTime":"0","summary":"Claritev expands Marpai partnership to add pre- and post-payment claims integrity servicesClaritev expanded its relationship with Marpai to provide pre- and post-payment integrity services across clai","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL69NhTD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4173","BK4167","CTEV","MRAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659121490","title":"Multiplan Board Authorizes Management to Proceed with Annual Business Plan Implementation","url":"https://stock-news.laohu8.com/highlight/detail?id=2659121490","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659121490?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:01","pubTimestamp":1786741316,"startTime":"0","endTime":"0","summary":"Multiplan board authorizes management to proceed with annual business plan implementationMultiplan’s board met Aug. 6, 2026 to review business performance, project execution, strategic priorities.Dire","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL1TKwVS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900686","title":"Claritev SVP, Chief Strategy Officer William B. Mintz Sells 8,431 Common Shares for $288,277.44","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900686","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900686?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:14","pubTimestamp":1786565673,"startTime":"0","endTime":"0","summary":"Claritev SVP, Chief Strategy Officer William B. Mintz sells 8,431 common shares for $288,277.44Claritev SVP, Chief Strategy Officer William B. Mintz sold 8,431 Class A common shares on Aug. 10, 2026.S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL6PZKmT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Claritev SVP, Chief Strategy Officer William B. Mintz Sells 8,431 Common Shares for $288,277.44","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658044979","title":"Press Release: Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2658044979","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658044979?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:00","pubTimestamp":1786532400,"startTime":"0","endTime":"0","summary":"-- Breakthrough results from V012 dialysis access Phase 3 study, where ATEV was observed to outperform AV fistula; supplemental Biologic License Application (sBLA) for dialysis access to be filed with","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","MAA","SPRE","BK4232","BK4563","AV","IND","R","BK4215","BK4167","HUMA","BK4022","BK4588","LABU","CTEV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658932071","title":"Claritev Analysts Raise Their Forecasts Following Q2 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2658932071","media":"Benzinga Earnings","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658932071?lang=en_us&edition=fundamental","pubTime":"2026-08-10 22:45","pubTimestamp":1786373120,"startTime":"0","endTime":"0","summary":"CTEV reported better-than-expected Q2 results and raised FY26 sales guidance. Analysts maintain Buy ratings with increased price targets.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/26/08/61078315/claritev-analysts-raise-their-forecasts-following-q2-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658931597","title":"Claritev Shifts Strategy to Earlier Cost Intelligence to Cut Avoidable Healthcare Spending","url":"https://stock-news.laohu8.com/highlight/detail?id=2658931597","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658931597?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:10","pubTimestamp":1786367409,"startTime":"0","endTime":"0","summary":"Claritev shifts strategy to earlier cost intelligence to cut avoidable healthcare spendingClaritev outlined a shift to act on healthcare cost drivers earlier in the care cycle, aiming to reduce avoida","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL7Xrsjk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658936458","title":"Claritev is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2658936458","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658936458?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:21","pubTimestamp":1786364460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CTEV/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658893374","title":"Guggenheim Sticks to Its Buy Rating for Claritev (CTEV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658893374","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658893374?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:37","pubTimestamp":1786361821,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Jason Cassorla reiterated a Buy rating on Claritev on August 7 and set a price target of $44.00. The company’s shares closed las...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-its-buy-rating-for-claritev-ctev-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-its-buy-rating-for-claritev-ctev-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658980569","title":"Claritev price target raised to $45 from $40 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2658980569","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658980569?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:40","pubTimestamp":1786358435,"startTime":"0","endTime":"0","summary":"Citi analyst Daniel Grosslight raised the firm’s price target on Claritev (CTEV) to $45 from $40 and keeps a Buy rating on the shares. Published fi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/claritev-price-target-raised-to-45-from-40-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/claritev-price-target-raised-to-45-from-40-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658893749","title":"Analysts Offer Insights on Healthcare Companies: Claritev (CTEV) and Qiagen (QGEN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658893749","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658893749?lang=en_us&edition=fundamental","pubTime":"2026-08-10 16:10","pubTimestamp":1786349406,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Claritev (CTEV) and Qiagen (QGEN) with bullish senti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-claritev-ctev-and-qiagen-qgen-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-claritev-ctev-and-qiagen-qgen-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XBI","BK4121","LU2125909247.SGD","LU2433249047.HKD","LU0029874061.USD","BK4585","BK4137","QGEN","HCSG","LU0128526141.USD","BK4581","LU1923622614.USD","CTEV","XLV","BK4588","LU2125909593.SGD","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658768607","title":"Claritev Corp : Canaccord Genuity Raises Target Price to $43 from $37","url":"https://stock-news.laohu8.com/highlight/detail?id=2658768607","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658768607?lang=en_us&edition=fundamental","pubTime":"2026-08-10 13:53","pubTimestamp":1786341192,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN44708E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657459649","title":"Claritev Corp Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657459649","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657459649?lang=en_us&edition=fundamental","pubTime":"2026-08-07 21:31","pubTimestamp":1786109510,"startTime":"0","endTime":"0","summary":"Claritev Corp reports results for the quarter ended June 30 - Earnings SummaryClaritev CorpCTEV.Nreported a quarterly adjusted loss of $3.49 per share for the quarter ended June 30, higher than the sa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4441G8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0417},{"period":"1month","weight":0.1571},{"period":"3month","weight":0.268},{"period":"6month","weight":1.3539},{"period":"1year","weight":-0.4773},{"period":"ytd","weight":-0.1179}],"compareEarnings":[{"period":"1week","weight":0.0055},{"period":"1month","weight":-0.0094},{"period":"3month","weight":0.0559},{"period":"6month","weight":0.15},{"period":"1year","weight":0.1805},{"period":"ytd","weight":0.1232}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"MultiPlan is committed to helping healthcare payors manage the cost of care, improve their competitiveness and inspire positive change. Leveraging sophisticated technology, data analytics, and a team rich with industry experience, MultiPlan interprets clients' needs and customizes innovative solutions that combine its payment integrity, network-based and analytics-based services. MultiPlan is a trusted partner to over 700 healthcare payors in the commercial health, dental, government and property and casualty markets. For more information, visit multiplan.com.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.061926},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.109417},{"month":3,"riseRate":0.5,"avgChangeRate":-0.000837},{"month":4,"riseRate":0.5,"avgChangeRate":0.097586},{"month":5,"riseRate":0.857143,"avgChangeRate":0.184077},{"month":6,"riseRate":0.857143,"avgChangeRate":0.150237},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.077934},{"month":8,"riseRate":0.428571,"avgChangeRate":0.050377},{"month":9,"riseRate":0,"avgChangeRate":-0.121019},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.018931},{"month":11,"riseRate":0,"avgChangeRate":-0.185403},{"month":12,"riseRate":0.666667,"avgChangeRate":0.131872}],"exchange":"NYSE","name":"Claritev Corporation","nameEN":"Claritev Corporation"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Claritev Corporation(CTEV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Claritev Corporation(CTEV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Claritev Corporation,CTEV,Claritev Corporation股票,Claritev Corporation股票老虎,Claritev Corporation股票老虎国际,Claritev Corporation行情,Claritev Corporation股票行情,Claritev Corporation股价,Claritev Corporation股市,Claritev Corporation股票价格,Claritev Corporation股票交易,Claritev Corporation股票购买,Claritev Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Claritev Corporation(CTEV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Claritev Corporation(CTEV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction